Chieh-Hsin Lin

Title: Chieh-Hsin Lin: Innovator in Alzheimer's Disease Diagnosis

Introduction

Chieh-Hsin Lin is a notable inventor based in Pingtung, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the area of Alzheimer's disease. His innovative approach utilizes specific biomarkers to enhance the accuracy of diagnosis and treatment.

Latest Patents

Chieh-Hsin Lin holds a patent for a method titled "Methods for diagnosing and treating Alzheimer's disease using G72 protein and SLC7A11 mRNA as biomarkers." This method involves obtaining a blood sample from a human subject suspected of having Alzheimer's disease. It includes determining the G72 protein level and SLC7A11 mRNA expression level in the blood sample. The results are compared to predetermined standards to diagnose the condition accurately. If diagnosed, an effective pharmaceutical composition may be administered to the subject for treatment. He has 1 patent related to this groundbreaking work.

Career Highlights

Throughout his career, Chieh-Hsin Lin has worked with reputable institutions such as Kaohsiung Chang Gung Memorial Hospital and China Medical University. His experience in these organizations has contributed to his expertise in medical research and innovation.

Collaborations

Chieh-Hsin Lin has collaborated with Hsien-Yuan Lane, further enhancing his research and development efforts in the field of Alzheimer's disease.

Conclusion

Chieh-Hsin Lin's innovative methods for diagnosing Alzheimer's disease represent a significant advancement in medical diagnostics. His work continues to pave the way for improved treatment options for patients suffering from this debilitating condition.